review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0165-0378(97)00063-6 |
P698 | PubMed publication ID | 9430743 |
P50 | author | Lawrence W. Chamley | Q39050378 |
P2860 | cites work | Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies | Q71556228 |
Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant | Q71593361 | ||
Antiphospholipid antibodies in patients with preeclampsia | Q71664624 | ||
Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes | Q71745317 | ||
Incidence of autoimmune antibodies in failed embryo transfer cycles | Q72102492 | ||
Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion | Q72361563 | ||
Antiphospholipid antibodies in pregnancy: prevalence and clinical associations | Q72551109 | ||
The effect of human anticardiolipin antibodies on murine pregnancy | Q72617269 | ||
Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages | Q73149303 | ||
Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI | Q73313674 | ||
The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions | Q24302208 | ||
Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I) | Q24303049 | ||
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) | Q24558202 | ||
Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein | Q28186234 | ||
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus | Q28261335 | ||
Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I | Q28304443 | ||
Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation | Q28305356 | ||
Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions | Q28575622 | ||
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3) | Q33364820 | ||
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies | Q33388194 | ||
Risk factors for thrombosis in lupus patients | Q33417102 | ||
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test | Q33453407 | ||
Anticardiolipin antibodies: isotype distribution and phospholipid specificity | Q33456927 | ||
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura | Q33459994 | ||
Induction of high levels of anticardiolipin antibodies in mice by immunization with beta 2-glycoprotein I does not cause fetal death | Q33487777 | ||
Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation | Q33493748 | ||
Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies | Q33557638 | ||
Complete amino acid sequence of human plasma beta 2-glycoprotein I. | Q36262293 | ||
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein | Q37358421 | ||
Current topic: pre-eclampsia and the placenta | Q37492460 | ||
Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis | Q39273389 | ||
The primary structure of rat beta 2-glycoprotein I. | Q40452588 | ||
Synthesis of beta2 glycoprotein 1 by the human placenta | Q41101472 | ||
The relationship between in vitro fertilization and naturally occurring antibodies: evidence for increased production of antiphospholipid autoantibodies | Q41141573 | ||
Nucleotide sequence and expression of the human gene encoding apolipoprotein H (β2-glycoprotein I) | Q41652765 | ||
Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein I | Q41674799 | ||
Characterization of binding of human beta 2-glycoprotein I to cardiolipin | Q41921283 | ||
Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface | Q42084495 | ||
Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies | Q43464737 | ||
Antiphospholipid antibodies in women having in-vitro fertilization | Q47870770 | ||
Antiphospholipid antibodies in pregnancy | Q47873939 | ||
Complete primary structure of bovine beta 2-glycoprotein I: localization of the disulfide bridges | Q48177667 | ||
Prospective study of anticardiolipin antibodies in stroke | Q49114000 | ||
Elution of anticardiolipin antibodies and their cofactor beta 2-glycoprotein 1 from the placentae of patients with a poor obstetric history. | Q52515218 | ||
Anticardiolipin antibody in the acquired immunodeficiency syndrome: a marker of Pneumocystis carinii infection? | Q58480277 | ||
Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach | Q61837755 | ||
The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population | Q61845862 | ||
Intrauterine death and circulating anticoagulant ("antithromboplastin") | Q66920894 | ||
Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times | Q67270296 | ||
IgM lupus anticoagulants can be associated with recurrent fetal loss and thrombotic episodes | Q67296952 | ||
Vascular Events in Placentae and Organ Allografts | Q67470052 | ||
A solid phase enzyme immunoassay (ELISA) for the detection and quantitation of anticardiolipin antibody | Q67945004 | ||
Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies | Q68037355 | ||
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor | Q68090535 | ||
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease | Q68091809 | ||
Assignment of apolipoprotein H (APOH: beta-2-glycoprotein I) to human chromosome 17q23----qter; determination of the major expression site | Q68120046 | ||
Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population | Q68343284 | ||
Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss | Q68528823 | ||
Syndrome of the black swan | Q69418368 | ||
Disulfide bonds are localized within the short consensus repeat units of complement regulatory proteins: C4b-binding protein | Q69529266 | ||
Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants | Q69685000 | ||
Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events | Q69874910 | ||
Cofactor dependent and cofactor independent anticardiolipin antibodies | Q70148532 | ||
beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles | Q70479801 | ||
Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera | Q70803296 | ||
An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation | Q70820108 | ||
Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein | Q71068052 | ||
P433 | issue | 1-2 | |
P921 | main subject | miscarriage | Q28693 |
autoantibody | Q785022 | ||
P304 | page(s) | 123-142 | |
P577 | publication date | 1997-11-01 | |
P1433 | published in | Journal of Reproductive Immunology | Q15755932 |
P1476 | title | Antiphospholipid antibodies or not? The role of beta 2 glycoprotein 1 in autoantibody-mediated pregnancy loss | |
P478 | volume | 36 |